text_1: GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments.
text_2: GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.